Why the study?
Does the Sabin live oral poliovaccine prevent poliomyelitis safely in children in Japan?
Population
Children in Japan, including 13 million aged 3 months to 5-9 years in 1961, and 17 million aged 3 months to…
Design
Review
Authors
Loading...
Supports historical impact of Sabin campaigns in Japan; leaves open applicability to current global eradication strategies.
Does the Sabin live oral poliovaccine prevent poliomyelitis safely in children in Japan?
The Sabin live oral poliovaccine was highly effective and safe in mass vaccination campaigns, leading to a dramatic decline in poliomyelitis cases in Japan and paving the way for disease eradication.
K Saito (1966) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: